Loading clinical trials...

Development of a Behavioral Team Intervention for Obsessive Compulsive Disorder | Clinical Trials | Clareo Health

COMPLETEDNA

Development of a Behavioral Team Intervention for Obsessive Compulsive Disorder

NCT02616341•Butler Hospital

Summary

The overall aim of this study is to determine modifications to Exposure and Response Prevention (ERP) therapy that are needed in order to effectively deliver treatment for Obsessive Compulsive Disorder (OCD) in a community mental health center. This study is the final study in a series of three projects executed to adapt and pilot-test a team ERP (T-ERP) intervention that will optimize therapist time by utilizing paraprofessionals to assist with group-ERP treatment plans. The intervention will be tailored to meet the unique needs of low-SES individuals with OCD and be implemented in a community mental health center (CMHC).

Eligibility

Age

18 - 65 years

Sex

ALL

Healthy Volunteers

Inclusion Criteria

•1. 18 Years to 65 Years
•2. English speaking
•3. Primary DSM-IV OCD (identified by the patient and therapist as the most problematic disorder over the past year)
•4. At least moderate severity OCD (YBOCS \> 16)
•5. Not currently on psychotropic medications or on the same psychotropic medications for at least 4 weeks prior to screening
•6. Have never received 10 or more sessions of ERP
•7. Not currently attending psychotherapy for OCD
•8. Low-income based on the U.S. Housing and Urban Development (HUDs) threshold for RI (less than $41,000 per year for individuals).

Exclusion Criteria

•1. Significant cognitive impairment (MMSE \< 25)
•2. Prominent suicidal ideation
•3. Current psychosis, mania, alcohol or drug dependence as assessed by the SCID-P.
•4. Prominent Hoarding

Key Dates

Start Date

November 1, 2012

Primary Completion Date

February 1, 2016

Completion Date

February 1, 2016

Last Updated

August 10, 2017

Enrollment

ACTUAL participants

Conditions

Obsessive Compulsive Disorder

Interventions

Team ERP (T-ERP) Intervention

BEHAVIORAL

Treatment as Usual (TAU)

BEHAVIORAL

Precision Analytic Research Methods in OCD

NCT07011901

Obsessive Compulsive Disorder

View study

RECRUITING

Pharmacogenomics of Selective Serotonin Reuptake Inhibitor (SSRI)-Induced Behavioural Activation

NCT06763081

Behavioral ActivationMajor Depressive Disorder+4 more

View study

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: August 10, 2017Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions

Development of a Behavioral Team Intervention for Obsessive Compulsive Disorder

Inclusion Criteria

Exclusion Criteria

Precision Analytic Research Methods in OCD

Pharmacogenomics of Selective Serotonin Reuptake Inhibitor (SSRI)-Induced Behavioural Activation

Brief Cognitive Behaviour Therapy (CBT) for Adolescent OCD in Routine Clinical Practice

Combined Cortical/Subcortical Recording and Stimulation as a Circuit-Oriented Treatment for Obsessive-Compulsive Disorder

NAC for Treatment-Resistant OCD and Other Related Disorders

Assessments of Obsessive-compulsive Symptoms in Patients With Substances Use Disorder